Where to Inject Wegovy: Finding the Most Effective Shot Location

Step 1: Choose your site and prepare the skin

Before anything else, pick one of the three approved areas: the lower abdomen (avoiding the 5 cm directly around your navel), the outer thigh, or the upper arm. The abdomen is the easiest site to self-inject because the skin is accessible and the fatty layer reliably subcutaneous. The thigh works well and is a natural second choice for rotation. The upper arm is the trickiest to self-administer, most people who use it have help from a partner or carer.

Once you have chosen your site, let the pen reach room temperature for around 30 minutes if it has come straight from the fridge. Injecting a cold pen is one of the most common causes of stinging, and it is entirely avoidable. Clean the skin with an alcohol swab and let it dry fully, wet skin can sting and may affect the seal around the pen tip.

The semaglutide overview on this site covers how the medicine works once it is absorbed, if you want that background before reading on.

Step 2: Inject at the right tissue depth, and rotate precisely

Wegovy is a subcutaneous injection: the needle goes into the fatty layer just under the skin, not into muscle. Pinching a small fold of skin before injecting helps if you are lean, ensuring the needle stays in the right layer. Hold the pen firmly against the skin, press the button, and keep it held in place for several seconds after the injection completes, the exact count is in your Patient Information Leaflet, and it matters for the full dose to be delivered.

Rotation is where many people take a shortcut they later regret. Using the same patch of skin week after week builds up fibrous or hardened tissue (lipodystrophy) that can reduce absorption unpredictably. The fix is simple: move at least 1–2 cm from last week's spot within the same broader site. A question our prescribers hear most weeks is whether rotating between sites is better than rotating within one, both work, and the NHS guidance recommends doing both.

You can read more detail on the practicalities in the Wegovy injection locations guide, which covers choosing between sites in more depth.

Step 3: Manage any local reactions and know when to change sites

Mild redness, itching, or a small bruise at the injection site are common in the first weeks of treatment and typically settle quickly. These are not a sign that you injected incorrectly or that the medicine is unsafe. The NHS semaglutide medicines page lists injection-site reactions among the common side effects and notes they are usually short-lived.

Persistent lumps, hardened skin, or significant bruising in one area are your signal to avoid that patch and let it recover. If a site becomes consistently uncomfortable, try a different approved area for a few weeks. Never inject through clothing, into broken or irritated skin, or into a mole or scar.

Some people find the abdomen produces the most consistent results simply because they can see what they are doing. Others prefer the thigh for discretion. There is no clinical evidence that one of the three sites produces meaningfully better weight-loss results than another, the medicine's absorption is comparable across all three when injected correctly, and our guide to which semaglutide formulation is most effective explains how other factors have a greater bearing on outcomes. The right site is the one you will use accurately and consistently every week.

For questions about how results vary by dose and duration, when Wegovy is most effective takes a closer look at the timeline of weight loss during treatment.

Side effects beyond the injection site: what to watch for

Wegovy's most common side effects are gastrointestinal: nausea, loose stools, constipation, indigestion, and occasionally vomiting, particularly after starting or stepping up a dose. These tend to ease as your body adjusts. Fatigue and headache are also reported, especially in the early weeks.

More serious signs require prompt medical attention: severe stomach pain that spreads to your back (a possible indicator of pancreatitis, flagged by the MHRA in their Drug Safety Update communications), signs of an allergic reaction, or symptoms of gallbladder problems. If you are uncertain whether a symptom needs urgent review, contact your prescriber or call 111. Report any suspected side effect via the MHRA Yellow Card scheme, the scheme helps regulators track safety signals across all patients on treatment.

If you are already on Wegovy and have questions about how effective it is proving for you, the page on whether Wegovy is effective sets out what the clinical evidence shows and what affects individual response. You can also find a detailed breakdown of the trial data and real-world figures on our page covering how effective semaglutide is, which is useful if you want to understand what typical results look like before drawing conclusions about your own progress. And if you are still deciding whether to start, check your eligibility with our prescribers, a free consultation is the first step, and one of our GPhC-registered prescribers reviews every application the same day.